Indication

Haemophilus influenzae type b infection

*Haemophilus influenzae* type b infection is a bacterial disease caused by the encapsulated, Gram-negative coccobacillus *Haemophilus influenzae* serotype b. Read more about Haemophilus influenzae type b infection

42 drugs 31 manufacturers

Advertisement

Drugs that treat it

Common Haemophilus influenzae type b infection therapies.

Showing 37–42 of 42 drugs

Filter & compare in the drug finder →Opens the drug finder with Haemophilus influenzae type b infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Haemophilus influenzae type b infection.

*Haemophilus influenzae* type b infection is a bacterial disease caused by the encapsulated, Gram-negative coccobacillus *Haemophilus influenzae* serotype b.

It predominantly affects infants and young children under five years of age, as well as immunocompromised or asplenic adults, following nasopharyngeal colonization and subsequent mucosal or hematogenous dissemination.

Pathophysiologically driven by its polyribosylribitol phosphate capsule, which evades phagocytosis, the pathogen can cause localized mucosal illness or progress to life-threatening invasive diseases, characteristically manifesting as acute bacterial meningitis, epiglottitis, bacteremic pneumonia, septic arthritis, and purulent bacteremia.

Personalize your experience

Follow Haemophilus influenzae type b infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it